Hims & Hers CTO receives 376,222 RSUs

Elshenawy Mohamed reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Elshenawy Mohamed reported acquisition or exercise transactions in this Form 4 filing.

Hims & Hers Health, Inc. reported that CTO Mohamed Elshenawy received a grant of 376,222 Restricted Stock Units, each representing a contingent right to receive one share of Class A Common Stock. This compensation award was recorded at a price of $0.00 per unit.

The RSUs are subject to a service-based vesting schedule over four years, vesting in substantially equal quarterly installments on March 15, June 15, September 15 and December 15. The first vesting date is June 15, 2026, and continued service is required for vesting. After this grant, Elshenawy’s reported derivative holdings total 376,222 RSUs.

Insider Trade Summary

Grant/Award: 376,222 shares

Grant/Award 1 txn

Insider Elshenawy Mohamed

Role CTO

Type	Security	Shares	Price	Value
Grant/Award	Restricted Stock Unit	376,222	$0.00	$0.00

Holdings After Transaction: Restricted Stock Unit — 376,222 contracts (Direct)

Footnotes (2)

1. F1. The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU.
2. F2. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2026.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Hims & Hers (HIMS) CTO Mohamed Elshenawy report on Form 4?

CTO Mohamed Elshenawy reported receiving a grant of 376,222 Restricted Stock Units from Hims & Hers Health, Inc. The RSUs are a form of equity compensation that convert into Class A Common Stock upon meeting service-based vesting requirements over a four-year period.

How many RSUs were granted to the Hims & Hers (HIMS) CTO in this filing?

The filing shows a grant of 376,222 Restricted Stock Units to CTO Mohamed Elshenawy. Each RSU corresponds to one share of Class A Common Stock, providing equity-based compensation that vests over time rather than an immediate cash payment or open-market share purchase.

How do the RSUs for Hims & Hers (HIMS) CTO vest over time?

The RSUs vest based on continued service over a four-year period. Vesting occurs in substantially equal quarterly installments on March 15, June 15, September 15 and December 15, gradually delivering shares rather than all at once, aligning compensation with ongoing employment.

When does vesting begin for Mohamed Elshenawy’s RSUs at Hims & Hers (HIMS)?

Vesting for Mohamed Elshenawy’s RSUs begins on June 15, 2026. That date is the first Company Quarterly Vesting Date, after which additional installments vest on March 15, June 15, September 15 and December 15 over the remaining four-year service-based vesting schedule.

What does each RSU represent in the Hims & Hers (HIMS) Form 4 filing?

Each Restricted Stock Unit represents a contingent right to receive one share of Hims & Hers Class A Common Stock. The units have a stated price of $0.00 and convert into actual shares only as the service-based vesting conditions are satisfied over the four-year schedule.

What are the CTO’s reported holdings after this RSU grant at Hims & Hers (HIMS)?

After the reported transaction, CTO Mohamed Elshenawy holds 376,222 Restricted Stock Units. These derivative holdings represent future rights to receive an equal number of Class A Common Stock shares, subject to the quarterly service-based vesting requirements described in the filing’s footnotes.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/13/2026 - 04:20 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Elshenawy Mohamed

(Last) (First) (Middle)

2269 CHESTNUT STREET, #523

(Street)

SAN FRANCISCO CA 94123

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Hims & Hers Health, Inc. [ HIMS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CTO

3. Date of Earliest Transaction (Month/Day/Year)
03/11/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Unit	(1)	03/11/2026		A		376,222		(2)	(2)	Class A Common Stock	376,222	$0	376,222	D

Explanation of Responses:

1. The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU.

2. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2026.

Remarks:

	/s/ Kimberly Mather, Attorney-in-Fact for Mohamed Elshenawy	03/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.